When follicular lymphoma becomes more aggressive — either by relapsing (coming back) or becoming refractory (resistant to treatment) — it typically requires more intensive treatment approaches. This is a challenging but manageable situation that doctors are well-equipped to address.
Treatment options at this stage may Show Full Answer
When follicular lymphoma becomes more aggressive — either by relapsing (coming back) or becoming refractory (resistant to treatment) — it typically requires more intensive treatment approaches. This is a challenging but manageable situation that doctors are well-equipped to address.
Treatment options at this stage may include:
- Switching therapies — moving to a different drug or combination if the current one isn't working
- Immunotherapy — treatments that help your immune system fight the cancer
- CAR T-cell therapy — an emerging and promising option, especially for relapsed or refractory cases
- Clinical trials — access to newer, cutting-edge treatments
- Radiation therapy — may be used in certain situations As for survival rates, even in advanced stages, the outlook for follicular lymphoma remains relatively positive compared to many other cancers:
- Stage 3 — five-year survival rate of around 89%
- Stage 4 — five-year survival rate of around 84%
- Overall — roughly 90% five-year survival rate across all stages
It's worth noting that survival rates have improved significantly over the decades thanks to newer treatments. While follicular lymphoma is generally not considered curable through conventional therapy, many people live for years — even decades — managing it effectively.
CAR T-cell therapy is showing early promise as a potential game-changer, though long-term outcome data is still being gathered. Always keep an open conversation with your care team about what options are best suited to your specific situation.
May 3
Join
Your Privacy Choices
